key: cord-0289216-chjdmkb7
authors: Zhao, Xuesen; Chen, Danying; Hao, Xiaohua; Qiu, Yaruo; Du, Juan; Zhang, Yuanyuan; Xiao, Fan; Li, Xinglin; Song, Yanjun; Song, Rui; Wang, Xi; Jin, Ronghua
title: Reduced Neutralization of SARS-CoV-2 Omicron Variant in Sera from SARS-CoV-1 Survivors after 3-dose of Vaccination
date: 2022-05-23
journal: bioRxiv
DOI: 10.1101/2022.05.21.492903
sha: 9e9e29fa07170d65998e51280ea7ce0c7ab12d4e
doc_id: 289216
cord_uid: chjdmkb7

Recent studies found that Omicron variant escapes vaccine-elicited immunity. Interestingly, potent cross-clade pan-sarbecovirus neutralizing antibodies were found in survivors of the infection by SARS-CoV-1 after BNT162b2 mRNA vaccination (N Engl J Med. 2021 Oct 7;385(15):1401-1406). These pan-sarbecovirus neutralizing antibodies were observed to efficiently neutralize the infection driven by the S protein from both SARS-CoV and multiple SARS-CoV-2 variants of concern (VOC) including B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta). However, whether these cross-reactive antibodies could neutralize the Omicron variant is still unknown. Based on the data collected from a cohort of SARS-CoV-1 survivors received 3-dose of immunization, our studies reported herein showed that a high level of neutralizing antibodies against both SARS-CoV-1 and SARS-CoV-2 were elicited by a 3rd-dose of booster vaccination of protein subunit vaccine ZF2001. However, a dramatically reduced neutralization of SARS-CoV-2 Omicron Variant (B.1.1.529) is observed in sera from these SARS-CoV-1 survivors received 3-dose of Vaccination. Our results indicates that the rapid development of pan-variant adapted vaccines is warranted.

antibodies were observed to efficiently neutralize the infection driven by the S protein 28 from both SARS-CoV and multiple SARS-CoV-2 variants of concern (VOC) including To address this question, sera samples were obtained from two panels of 48 participants ( Fig. S1 and Table S1 ). The SARS-CoV-1 survivors panel comprised 18 The third dose of ZF2001 vaccine rapidly induced a significant increase in 58 humoral immune response. As shown in figure 1A and S3, the geometric mean titers Table S1 . spike mutations T19R, G142D, Δ156-157, R158G, A222V, L452R, T478K, 

2018ZX10301-408-002) to X.Z.，National Science Foundation of China 256 (82102363) to D.C. and Beijing Natural Science Foundation (M21007) to

Variant Neutralization in Serum from Vaccinated and Convalescent Persons

Considerable escape of SARS-CoV-2 Omicron 270 to antibody neutralization

A novel coronavirus associated with 272 severe acute respiratory syndrome

Pan-Sarbecovirus Neutralizing Antibodies in 274

BNT162b2-Immunized SARS-CoV-1 Survivors

Humoral immunogenicity and reactogenicity of 276

CoronaVac or ZF2001 booster after two doses of inactivated vaccine